Antonio Vega

Antonio Vega

Auto-generated profile, based on publicly available information

Antonio Vega

Laboratorio de Inmunología y Alergia-FISEVI, UGC de Alergología. Hospital Universitario Virgen Macarena, Spain

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2003 in Blood
Verified
Journal Article
Closed access
RBRajaa El Bekay
Rajaa El Bekay
MAMoisés ÁlVarez
Moisés ÁlVarez
JMJavier Monteseirín
Javier Monteseirín
GAGonzalo ÁlBa
Gonzalo ÁlBa
PCPedro Chacón
Pedro Chacón
FSFrancisco Sobrino
Francisco Sobrino
Neutrophils are mobilized to the vascular wall during vessel inflammation. Published data are conflicting on phagocytic nicotinamide-adenine dinucleotide phosphate (NADPH) oxidase activation during the hypertensive state, and the capacity of angiotensin II (Ang II) to modulate the intracellular redox status has not been analyzed in neutrophils. We here describe that Ang II highly stimulates endogenous and extracellular O2- production in these cells, consistent with the translocation to the cell membrane of the cytosolic components of NADPH oxidase, p47phox, and p67phox. The Ang II–dependent O2- production was suppressed by specific inhibitors of AT1 receptors, of the p38MAPK and ERK1/2 pathways, and of flavin oxidases. Furthermore, Ang II induced a robust phosphorylation of p38MAPK, ERK1/2, and JNK1/2 (particularly JNK2), which was hindered by inhibitors of NADPH oxidase, tyrosine kinases, and ROS scavengers. Ang II increased cytosolic Ca2+ levels—released mainly from calcium stores—enhanced the synthesis de novo and activity of calcineurin, and stimulated the DNA-binding activity of the transcription factor NF-κB in cultured human neutrophils. Present data demonstrate for the first time a stimulatory role of Ang II in the activation of phagocytic cells, underscore the relevant role of ROS as mediators in this process, and uncover a variety of signaling pathways by which Ang II operates in human neutrophils.

1 May 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MÁMoisés Álvarez-Maqueda
Moisés Álvarez-Maqueda
RBRajaa El Bekay
Rajaa El Bekay
GJGonzalo Jiménez
Gonzalo Jiménez
JMJavier Monteseirín
Javier Monteseirín
PCPedro Chacón
Pedro Chacón
FSFrancisco Sobrino
Francisco Sobrino
15-Deoxy-delta(12,14)-prostaglandin J(2) (15dPGJ(2) has been recently proposed as a potent anti-inflammatory agent. However, the mechanisms by which 15dPGJ(2) mediates its therapeutic effects in vivo are unclear. We demonstrate that 15dPGJ(2) at micromolar (2.5-10 microm) concentrations induces the expression of heme oxygenase-1 (HO-1), an anti-inflammatory enzyme, at both mRNA and protein levels in human lymphocytes. In contrast, troglitazone and ciglitazone, two thiazolidinediones that mimic several effects of 15dPGJ(2) through their binding to the peroxisome proliferator-activated receptor (PPAR)-gamma, did not affect HO-1 expression, and the positive effect of 15dPGJ(2) on this process was mimicked instead by other cyclopentenone prostaglandins (PG), such as PGD(2) (the precursor of 15dPGJ(2)) and PGA(1) and PGA(2) which do not interact with PPAR-gamma. Also, 15dPGJ(2) enhanced the intracellular production of reactive oxygen species (ROS) and increased xanthine oxidase activity in vitro. Inhibition of intracellular ROS production by N-acetylcysteine, TEMPO, Me(2)SO, 1,10-phenanthroline, or allopurinol resulted in a decreased 15dPGJ(2)-dependent HO-1 expression in the cells. Furthermore, buthionine sulfoximine, an inhibitor of reduced glutathione synthesis, or Fe(2+)/Cu(2+) ions enhanced the positive effect of 15dPGJ(2) on HO-1 expression. On the other hand, the inhibition of phosphatidylinositol 3-kinase or p38 mitogen-activated protein kinase, or the blockade of transcription factor NF-kappaB activation, hindered 15dPGJ(2)-elicited HO-1 expression. Collectively, the present data suggest that 15dPGJ(2) anti-inflammatory actions at pharmacological concentrations involve the induction of HO-1 gene expression through mechanisms independent of PPAR-gamma activation and dependent on ROS produced via the xanthine/xanthine oxidase system and/or through Fenton reactions. Both phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways also appear implicated in modulation of HO-1 expression by 15dPGJ(2).

9 August 2004 in FEBS Letters
Verified
Journal Article
Closed access
GJGonzalo Jiménez
Gonzalo Jiménez
RBRajaa El Bekay
Rajaa El Bekay
MÁMoisés Álvarez-Maqueda
Moisés Álvarez-Maqueda
PCPedro Chacón
Pedro Chacón
AVAntonio Vega
Antonio Vega
FSFrancisco Sobrino
Francisco Sobrino

29 April 2014 in Allergy
Verified
Journal Article
Closed access
PDF file
IVI. Ventura
I. Ventura
AVA. Vega
A. Vega
PCP. Chacón
P. Chacón
CCC. Chamorro
C. Chamorro
RAR. Aroca
R. Aroca
JMJavier Monteseirin
Javier Monteseirin

1 February 2004 in Atherosclerosis
Verified
Journal Article
Closed access
MAMoisés Alvarez-Maqueda
Moisés Alvarez-Maqueda
RBRajaa El Bekay
Rajaa El Bekay
JMJavier Monteseirín
Javier Monteseirín
GJGonzalo Jiménez
Gonzalo Jiménez
PCPedro Chacón
Pedro Chacón
FSFrancisco Sobrino
Francisco Sobrino

15 August 2007 in The Journal of Immunology
Verified
Journal Article
Closed access
JMJavier Monteseirín
Javier Monteseirín
AVAntonio Vega
Antonio Vega
PCPedro Chacón
Pedro Chacón
MCM Jesús Camacho
M Jesús Camacho
RBRajaa El Bekay
Rajaa El Bekay
AJAsturias Ja
Asturias Ja
The production of eosinophil cationic protein (ECP) in IgE-mediated diseases has been associated mainly with eosinophils, although no IgE-dependent ECP release has been observed in these cells. Because there is increasing evidence of neutrophil participation in allergic processes, we have examined whether human neutrophils from allergic patients were able to produce ECP by an IgE-dependent mechanism. After challenge with specific Ags to which the patients were sensitized, ECP release was detected in the culture medium. Furthermore, intracellular protein was detected by flow cytometry, immunofluorescence staining, and Western blotting. Expression at both mRNA and de novo protein synthesis were detected, respectively, by RT-PCR and radiolabeling with 35S. Ag effect was mimicked by cell treatment with anti-IgE Abs or Abs against FcεRI and galectin-3 (FcεRI>galectin-3), but not against FcεRII. These observations represent a novel view of neutrophils as possible source of ECP in IgE-dependent diseases.